Based on the results from bladder cancer tissues, we hypothesized that DNMT3B reduced the expression of miR-34a via miR-34a promoter methylation, which was verified using bladder cancer cell lines. The gene discussed is DNMT3B; the disease is urinary bladder carcinoma.